Hospitals & Services
The United States, National Institue for Occupational Safety and Health Hazardous Drug (NIOSH) list has ganciclivor listed as a hazardous drug.
This means that particular safe handling and administration guidelines should be followed. It is recommended that the following PPE be worn when administering ganciclovir.
Below is a table outlining the training requirements that need to be completed before you can administer ganciclovir. The eviQ course can be found on healthLearn. Competency sign off can be achieved with either the nurse educator or the clinical nurse specialist that works in your area. Re-certification is not required.
Please contact the Haematology/Oncology Nurse Educators if you require further information/support.
eviQ ADAC course - Adult antineoplastic drug administration for the non-cancer setting (RGMC003)